HomeADPT • NASDAQ
add
Adaptive Biotechnologies Corp
Previous close
$3.90
Day range
$3.69 - $3.95
Year range
$2.28 - $9.08
Market cap
548.21M USD
Avg Volume
1.87M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 41.87M | 11.23% |
Operating expense | 67.90M | -5.18% |
Net income | -47.51M | 17.66% |
Net profit margin | -113.45 | 25.98% |
Earnings per share | -0.32 | 20.33% |
EBITDA | -43.55M | 15.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 308.87M | -29.91% |
Total assets | 620.32M | -21.62% |
Total liabilities | 345.56M | -5.97% |
Total equity | 274.77M | — |
Shares outstanding | 147.37M | — |
Price to book | 2.09 | — |
Return on assets | -19.03% | — |
Return on capital | -23.43% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -47.51M | 17.66% |
Cash from operations | -38.35M | 35.16% |
Cash from investing | 44.51M | -29.33% |
Cash from financing | 44.00K | -93.45% |
Net change in cash | 6.20M | 37.81% |
Free cash flow | -20.99M | 43.59% |
About
CEO
Founded
2009
Headquarters
Website
Employees
709